Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vinod Nargund

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Urologic Nursing|August 10, 2016
Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part IBruce Turner, Lawrence Drudge-Coates, Sacha Ali, et al.
BJU International|May 17, 2005
Imaging with radiolabelled monoclonal antibody (MUJ591) to prostate-specific membrane antigen in staging of clinically localized prostatic carcinoma: comparison with clinical, surgical and histological stagingVinod Nargund, Dona Al Hashmi, Priya Kumar, et al.
BJU International|February 9, 2008
Stage migration and pilot studies of reduced chemotherapy supported by positron-emission tomography findings suggest new combined strategies for stage 2 nonseminoma germ cell tumourYasser Haba, Michael V Williams, David E Neal, et al.
European Urology|March 21, 2007
The risk of prostate cancer amongst black men in the United Kingdom: the PROCESS cohort studyYoav Ben-Shlomo, Simon Evans, Fowzia Ibrahim, et al.
BJU International|June 11, 2008
The risk of prostate cancer amongst South Asian men in southern England: the PROCESS cohort studyChris Metcalfe, Biral Patel, Simon Evans, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Urologic Nursing|August 10, 2016
Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part IBruce Turner, Lawrence Drudge-Coates, Sacha Ali, et al.
BJU International|May 17, 2005
Imaging with radiolabelled monoclonal antibody (MUJ591) to prostate-specific membrane antigen in staging of clinically localized prostatic carcinoma: comparison with clinical, surgical and histological stagingVinod Nargund, Dona Al Hashmi, Priya Kumar, et al.
BJU International|February 9, 2008
Stage migration and pilot studies of reduced chemotherapy supported by positron-emission tomography findings suggest new combined strategies for stage 2 nonseminoma germ cell tumourYasser Haba, Michael V Williams, David E Neal, et al.
European Urology|March 21, 2007
The risk of prostate cancer amongst black men in the United Kingdom: the PROCESS cohort studyYoav Ben-Shlomo, Simon Evans, Fowzia Ibrahim, et al.
BJU International|June 11, 2008
The risk of prostate cancer amongst South Asian men in southern England: the PROCESS cohort studyChris Metcalfe, Biral Patel, Simon Evans, et al.
Pageof 2